{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:21:46Z","timestamp":1787170906083,"version":"build-2736575974"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>To examine the effect of botulinum toxin A (BoNT-A) on neural mechanisms underlying pain and photophobia using functional magnetic resonance imaging (fMRI) in individuals with chronic ocular pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twelve subjects with chronic ocular pain and light sensitivity were recruited from the Miami Veterans Affairs eye clinic. Inclusion criteria were: (1) chronic ocular pain; (2) presence of ocular pain over 1\u2009week recall; and (3) presence of photophobia. All individuals underwent an ocular surface examination to capture tear parameters before and 4\u20136\u2009weeks after BoNT-A injections. Using an event-related fMRI design, subjects were presented with light stimuli during two fMRI scans, once before and 4\u20136\u2009weeks after BoNT-A injection. Light evoked unpleasantness ratings were reported by subjects after each scan. Whole brain blood oxygen level dependent (BOLD) responses to light stimuli were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At baseline, all subjects reported unpleasantness with light stimulation (average: 70.8\u2009\u00b1\u200932.0). Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1\u2009\u00b1\u200933.6), but the change was not significant. On an individual level, 50% of subjects had decreased unpleasantness ratings in response to light stimulation compared to baseline (\u201cresponders,\u201d\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096), while 50% had equivalent (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093) or increased (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093) unpleasantness (\u201cnon-responders\u201d). At baseline, several differences were noted between responders and non-responders; responders had higher baseline unpleasantness ratings to light, higher symptoms of depression, and more frequent use of antidepressants and anxiolytics, compared to non-responders. Group analysis at baseline displayed light-evoked BOLD responses in bilateral primary somatosensory (S1), bilateral secondary somatosensory (S2), bilateral anterior insula, paracingulate gyrus, midcingulate cortex (MCC), bilateral frontal pole, bilateral cerebellar hemispheric lobule VI, vermis, bilateral cerebellar crus I and II, and visual cortices. BoNT-A injections significantly decreased light evoked BOLD responses in bilateral S1, S2 cortices, cerebellar hemispheric lobule VI, cerebellar crus I, and left cerebellar crus II. BoNT-A responders displayed activation of the spinal trigeminal nucleus at baseline where non-responders did not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>BoNT-A injections modulate light-evoked activation of pain-related brain systems and photophobia symptoms in some individuals with chronic ocular pain. These effects are associated with decreased activation in areas responsible for processing the sensory-discriminative, affective, dimensions, and motor responses to pain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2023.1202341","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T04:08:50Z","timestamp":1687147730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia"],"prefix":"10.3389","volume":"17","author":[{"given":"Nicholas","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaxon J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjalee","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pondelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyana V.","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip M.","family":"Pattany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Galor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s12311-016-0815-8","article-title":"Consensus paper: cerebellum and emotion","volume":"16","author":"Adamaszek","year":"2017","journal-title":"Cerebellum"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/08164622.2021.1951600","article-title":"Accommodative response to ocular surface pain","volume":"105","author":"Alabi","year":"2022","journal-title":"Clin. Exp. Optom."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4155\/cli.14.135","article-title":"Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence","volume":"5","author":"Ames","year":"2015","journal-title":"Clin Investig (Lond)."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/eye.2017.275","article-title":"Corneal sensitivity and subjective complaints of ocular pain in patients with fibromyalgia","volume":"32","author":"Aykut","year":"2018","journal-title":"Eye (Lond.)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/EB.S234073","article-title":"Exploring the link between dry eye and migraine: from eye to brain","volume":"13","author":"Baksh","year":"2021","journal-title":"Eye Brain."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1126\/science.1067262","article-title":"Phototransduction by retinal ganglion cells that set the circadian clock","volume":"295","author":"Berson","year":"2002","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1054\/jpai.2002.27142","article-title":"The use of botulinum toxin for the treatment of chronic facial pain","volume":"3","author":"Borodic","year":"2002","journal-title":"J. Pain"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cne.20688","article-title":"Unitary hypothesis for multiple triggers of the pain and strain of migraine","volume":"493","author":"Burstein","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","article-title":"Validation of the 5-item dry eye questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses","volume":"33","author":"Chalmers","year":"2010","journal-title":"Cont. Lens Anterior Eye"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/WNF.0b013e31826538c7","article-title":"Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia","volume":"35","author":"Charles","year":"2012","journal-title":"Clin. Neuropharmacol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ajo.2022.09.020","article-title":"Clinical neuroimaging of photophobia in individuals with chronic ocular surface pain","volume":"246","author":"Choudhury","year":"2023","journal-title":"Am J. Ophthalmol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1136\/bjophthalmol-2016-309658","article-title":"Evidence of central sensitisation in those with dry eye symptoms and neuropathic-like ocular pain complaints: incomplete response to topical anaesthesia and generalised heightened sensitivity to evoked pain","volume":"101","author":"Crane","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/bjophthalmol-2015-308214","article-title":"Patients with more severe symptoms of neuropathic ocular pain report more frequent and severe chronic overlapping pain conditions and psychiatric disease","volume":"101","author":"Crane","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/0333102414547782","article-title":"Measurement of visual sensitivity in migraine: validation of two scales and correlation with visual cortex activation","volume":"35","author":"Cucchiara","year":"2015","journal-title":"Cephalalgia"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"E004","DOI":"10.1017\/S0952523817000359","article-title":"Melanopsin expression in the cornea","volume":"35","author":"Delwig","year":"2018","journal-title":"Vis. Neurosci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12311-015-0706-4","article-title":"Cerebellar clustering and functional connectivity during pain processing","volume":"15","author":"Diano","year":"2016","journal-title":"Cerebellum"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.ophtha.2017.08.004","article-title":"Neuropathic corneal pain: approaches for management","volume":"124","author":"Dieckmann","year":"2017","journal-title":"Ophthalmology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/bjophthalmol-2018-312649","article-title":"Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin a injections","volume":"103","author":"Diel","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1136\/bjophthalmol-2020-316417","article-title":"Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway","volume":"105","author":"Diel","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/WNO.0b013e3182474548","article-title":"Shedding light on photophobia","volume":"32","author":"Digre","year":"2012","journal-title":"J. Neuroophthalmol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3389\/fneur.2020.00716","article-title":"Botulinum neurotoxin for the treatment of neuropathic pain","volume":"11","author":"Egeo","year":"2020","journal-title":"Front. Neurol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00702-013-1048-3","article-title":"A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(\u00ae) in cervical dystonia)","volume":"120","author":"Evidente","year":"2013","journal-title":"J. Neural Transm."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bjophthalmol-2018-313471","article-title":"Individuals with migraine have a different dry eye symptom profile than individuals without migraine","volume":"104","author":"Farhangi","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1097\/j.pain.0000000000001552","article-title":"Modification of the neuropathic pain symptom inventory for use in eye pain (NPSI-eye)","volume":"160","author":"Farhangi","year":"2019","journal-title":"Pain"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/bjophthalmol-2015-307094","article-title":"Incomplete response to artificial tears is associated with features of neuropathic ocular pain","volume":"100","author":"Galor","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jpain.2015.10.019","article-title":"Neuropathic ocular pain due to dry eye is associated with multiple comorbid chronic pain syndromes","volume":"17","author":"Galor","year":"2016","journal-title":"J. Pain"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ophtha.2020.07.061","article-title":"Corneal nerve pathway function in individuals with dry eye symptoms","volume":"128","author":"Galor","year":"2021","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ajo.2012.02.009","article-title":"Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States veterans affairs administrative database","volume":"154","author":"Galor","year":"2012","journal-title":"Am J. Ophthalmol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jtos.2017.10.001","article-title":"Neuropathic pain and dry eye","volume":"16","author":"Galor","year":"2018","journal-title":"Ocul. Surf."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41398-020-01036-5","article-title":"Common and distinct patterns of intrinsic brain activity alterations in major depression and bipolar disorder: voxel-based meta-analysis","volume":"10","author":"Gong","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1097\/j.pain.0000000000000702","article-title":"Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine","volume":"157","author":"Guo","year":"2016","journal-title":"Pain"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/cercor\/bhn104","article-title":"The link between facial feedback and neural activity within central circuitries of emotion--new insights from botulinum toxin-induced denervation of frown muscles","volume":"19","author":"Hennenlotter","year":"2009","journal-title":"Cereb. Cortex"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/0333102411409076","article-title":"fMRI evidence that precision ophthalmic tints reduce cortical hyperactivation in migraine","volume":"31","author":"Huang","year":"2011","journal-title":"Cephalalgia"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40135-017-0152-1","article-title":"Diagnosis and treatment of ocular pain: the ophthalmologist's perspective","volume":"5","author":"Jacobs","year":"2017","journal-title":"Curr Ophthalmol Rep."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/mds.23658","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial","volume":"26","author":"Jankovic","year":"2011","journal-title":"Mov. Disord."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"15439","DOI":"10.1523\/JNEUROSCI.3265-12.2012","article-title":"Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B\/D) agonist","volume":"32","author":"Kaiser","year":"2012","journal-title":"J. Neurosci."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/ICL.0000000000000249","article-title":"Characteristics of ocular pain complaints in patients with idiopathic dry eye symptoms","volume":"43","author":"Kalangara","year":"2017","journal-title":"Eye Contact Lens"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/pm\/pnv070","article-title":"Burning eye syndrome: do neuropathic pain mechanisms underlie chronic dry eye?","volume":"17","author":"Kalangara","year":"2016","journal-title":"Pain Med."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuroscience.2013.04.053","article-title":"Posterior hypothalamic modulation of light-evoked trigeminal neural activity and lacrimation","volume":"246","author":"Katagiri","year":"2013","journal-title":"Neuroscience"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"684926","DOI":"10.3389\/fnins.2021.684926","article-title":"Effects of chronic pain treatment on altered functional and metabolic activities in the brain: a systematic review and Meta-analysis of functional neuroimaging studies","volume":"15","author":"Kim","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e1292","DOI":"10.1371\/journal.pone.0001292","article-title":"What are you feeling? Using functional magnetic resonance imaging to assess the modulation of sensory and affective responses during empathy for pain","volume":"2","author":"Lamm","year":"2007","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/08164622.2021.1962210","article-title":"Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease","volume":"105","author":"Lee","year":"2022","journal-title":"Clin. Exp. Optom."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/OPTH.S126668","article-title":"Dry eye syndrome: developments and lifitegrast in perspective","volume":"12","author":"Lollett","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4088\/JCP.13m08845","article-title":"Treatment of major depressive disorder using botulinum toxin a: a 24-week randomized, double-blind, placebo-controlled study","volume":"75","author":"Magid","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3389\/fnins.2019.00497","article-title":"Implication of Melanopsin and trigeminal neural pathways in blue light photosensitivity in vivo","volume":"13","author":"Marek","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fncir.2016.00060","article-title":"Peripheral sensory neurons expressing melanopsin respond to light","volume":"10","author":"Matynia","year":"2016","journal-title":"Front Neural Circuits."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"11077-1114","DOI":"10.1111\/ner.13402","article-title":"Long-term trigeminal nerve stimulation as a treatment for ocular pain","volume":"24","author":"Mehra","year":"2021","journal-title":"Neuromodulation"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1523\/JNEUROSCI.5490-08.2009","article-title":"Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential","volume":"29","author":"Meng","year":"2009","journal-title":"J. Neurosci."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s12325-020-01427-6","article-title":"IncobotulinumtoxinA for the treatment of Blepharospasm in toxin-Na\u00efve subjects: a multi-center, double-blind, randomized","volume":"37","author":"Mitsikostas","year":"2020","journal-title":"Placebo Controlled Trial. Adv. Ther."},{"key":"ref52","first-page":"28","article-title":"Ocular neuropathic pain","volume-title":"StatPearls","author":"Moshirfar","year":"2022"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.pain.2009.07.018","article-title":"An fMRI case report of photophobia: activation of the trigeminal nociceptive pathway","volume":"145","author":"Moulton","year":"2009","journal-title":"Pain"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1523\/JNEUROSCI.6709-10.2011","article-title":"Aversion-related circuitry in the cerebellum: responses to noxious heat and unpleasant images","volume":"31","author":"Moulton","year":"2011","journal-title":"J. Neurosci."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.brainresrev.2010.05.005","article-title":"The cerebellum and pain: passive integrator or active participator?","volume":"65","author":"Moulton","year":"2010","journal-title":"Brain Res. Rev."},{"key":"ref56","year":"2023"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","article-title":"Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain","volume":"154","author":"Noseda","year":"2013","journal-title":"Pain"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nn.2475","article-title":"A neural mechanism for exacerbation of headache by light","volume":"13","author":"Noseda","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neuroscience.2009.03.003","article-title":"Bright light produces Fos-positive neurons in caudal trigeminal brainstem","volume":"160","author":"Okamoto","year":"2009","journal-title":"Neuroscience"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/bjophthalmol-2017-310633","article-title":"Epidemiology of discordance between symptoms and signs of dry eye","volume":"102","author":"Ong","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/PRA.0000000000000136","article-title":"Role of botulinum toxin in depression","volume":"22","author":"Parsaik","year":"2016","journal-title":"J. Psychiatr. Pract."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"788524","DOI":"10.3389\/fphar.2021.788524","article-title":"Differential effects of treatment strategies in individuals with chronic ocular surface pain with a neuropathic component","volume":"12","author":"Patel","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10194-016-0621-1","article-title":"The efficiency of botulinum toxin type a for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache","volume":"17","author":"Pihut","year":"2016","journal-title":"J. Headache Pain"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1523\/JNEUROSCI.21-24-09896.2001","article-title":"Exacerbation of pain by anxiety is associated with activity in a hippocampal network","volume":"21","author":"Ploghaus","year":"2001","journal-title":"J. Neurosci."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1126\/science.284.5422.1979","article-title":"Dissociating pain from its anticipation in the human brain","volume":"284","author":"Ploghaus","year":"1999","journal-title":"Science"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1523\/JNEUROSCI.22-08-03206.2002","article-title":"Does anticipation of pain affect cortical nociceptive systems?","volume":"22","author":"Porro","year":"2002","journal-title":"J. Neurosci."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ajo.2011.11.030","article-title":"Impact of ocular surface symptoms on quality of life in a United States veterans affairs population","volume":"153","author":"Pouyeh","year":"2012","journal-title":"Am J. Ophthalmol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.neuroscience.2014.07.052","article-title":"Trigeminal pathways for hypertonic saline- and light-evoked corneal reflexes","volume":"277","author":"Rahman","year":"2014","journal-title":"Neuroscience"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jpain.2021.11.010","article-title":"Self-report of severity of ocular pain due to light as a predictor of altered central nociceptive system processing in individuals with symptoms of dry eye disease","volume":"23","author":"Rodriguez","year":"2022","journal-title":"J. Pain"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1542-0124(12)70290-2","article-title":"Corneal pain without stain: is it real?","volume":"7","author":"Rosenthal","year":"2009","journal-title":"Ocul. Surf."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jtos.2012.01.002","article-title":"The corneal pain system. Part I: the missing piece of the dry eye puzzle","volume":"10","author":"Rosenthal","year":"2012","journal-title":"Ocul. Surf."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/bjophthalmol-2019-314799","article-title":"Clinical and in vivo confocal microscopic features of neuropathic corneal pain","volume":"104","author":"Ross","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"e1973","DOI":"10.1212\/WNL.0000000000005622","article-title":"Visual stimulation leads to activation of the nociceptive trigeminal nucleus in chronic migraine","volume":"90","author":"Schulte","year":"2018","journal-title":"Neurology"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1474-4422(14)70193-0","article-title":"Functional MRI of migraine","volume":"14","author":"Schwedt","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"3284446","DOI":"10.1155\/2022\/3284446","article-title":"Botox (OnabotulinumtoxinA) for treatment of migraine symptoms: a systematic review","volume":"2022","author":"Shaterian","year":"2022","journal-title":"Pain Res. Manag."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bdi.13176","article-title":"Distinguishing between depression in bipolar disorder and unipolar depression using magnetic resonance imaging: a systematic review","volume":"24","author":"Siegel-Ramsay","year":"2022","journal-title":"Bipolar Disord."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","article-title":"Botulinum toxin type a as a migraine preventive treatment. For the BOTOX migraine clinical research group","volume":"40","author":"Silberstein","year":"2000","journal-title":"Headache"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/ICL.0000000000000630","article-title":"Oral gabapentinoids and nerve blocks for the treatment of chronic ocular pain","volume":"46","author":"Small","year":"2020","journal-title":"Eye Contact Lens"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.bja.2019.03.033","article-title":"The sensory and affective components of pain: are they differentially modifiable dimensions or inseparable aspects of a unitary experience? A systematic review","volume":"123","author":"Talbot","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ajo.2015.11.017","article-title":"Clinical characteristics of dry eye patients with chronic pain syndromes","volume":"162","author":"Vehof","year":"2016","journal-title":"Am J. Ophthalmol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"100809","DOI":"10.1016\/j.ajoc.2020.100809","article-title":"Periorbital botulinum toxin a improves photophobia and sensations of dryness in patients without migraine: case series of four patients","volume":"19","author":"Venkateswaran","year":"2020","journal-title":"Am J Ophthalmol Case Rep."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14060383","article-title":"Treatment of depression with botulinum toxin","volume":"14","author":"Wollmer","year":"2022","journal-title":"Toxins (Basel)."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.neubiorev.2020.01.004","article-title":"Convergent neural representations of experimentally-induced acute pain in healthy volunteers: a large-scale fMRI meta-analysis","volume":"112","author":"Xu","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/jamaophthalmol.2022.0140","article-title":"Association between depression and severity of dry eye symptoms, signs, and inflammatory markers in the DREAM study","volume":"140","author":"Zhou","year":"2022","journal-title":"JAMA Ophthalmol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1202341\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T04:35:57Z","timestamp":1697171757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1202341\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":85,"alternative-id":["10.3389\/fnins.2023.1202341"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1202341","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"article-number":"1202341"}}